K. KARADENİZ CERİT Et Al. , "The antifibrotic drug halofuginone reduces ischemia/reperfusion-induced oxidative renal damage in rats," JOURNAL OF PEDIATRIC UROLOGY , vol.9, pp.174-183, 2013
KARADENİZ CERİT, K. Et Al. 2013. The antifibrotic drug halofuginone reduces ischemia/reperfusion-induced oxidative renal damage in rats. JOURNAL OF PEDIATRIC UROLOGY , vol.9 , 174-183.
KARADENİZ CERİT, K., Karakoyun, B., YÜKSEL, M., ÖZKAN, N., ÇETİNEL, Ş., Dagli, E. T. , ... YEGEN, B.(2013). The antifibrotic drug halofuginone reduces ischemia/reperfusion-induced oxidative renal damage in rats. JOURNAL OF PEDIATRIC UROLOGY , vol.9, 174-183.
KARADENİZ CERİT, KIVILCIM Et Al. "The antifibrotic drug halofuginone reduces ischemia/reperfusion-induced oxidative renal damage in rats," JOURNAL OF PEDIATRIC UROLOGY , vol.9, 174-183, 2013
KARADENİZ CERİT, KIVILCIM K. Et Al. "The antifibrotic drug halofuginone reduces ischemia/reperfusion-induced oxidative renal damage in rats." JOURNAL OF PEDIATRIC UROLOGY , vol.9, pp.174-183, 2013
KARADENİZ CERİT, K. Et Al. (2013) . "The antifibrotic drug halofuginone reduces ischemia/reperfusion-induced oxidative renal damage in rats." JOURNAL OF PEDIATRIC UROLOGY , vol.9, pp.174-183.
@article{article, author={KIVILCIM KARADENİZ CERİT Et Al. }, title={The antifibrotic drug halofuginone reduces ischemia/reperfusion-induced oxidative renal damage in rats}, journal={JOURNAL OF PEDIATRIC UROLOGY}, year=2013, pages={174-183} }